BioLife Plasma Services Announces Opening of First Plasma Collection Center in Nebraska
BioLife Plasma Services (www.biolifeplasma.com), part of the global biopharmaceutical company Takeda Pharmaceutical Company Limited, opened a new plasma collection center in Omaha, 275 N 78th St., on October 24 to collect standard plasma from healthy donors. The Omaha center is approximately 11,330 square feet, and the state-of-the-art facility provides access to free Wi-Fi and a clean, professional, smoke-free environment. The new center is the first BioLife center to open in Nebraska and expects to bring more than 50 new jobs to the community.
“Now, more than ever, donors in the Omaha area have a unique opportunity to make a difference in the community through plasma donation, and we are deeply committed to making treatment options available for patients who rely on plasma-derived medications,” said Jacy Cizek, manager of the BioLife Plasma Services Omaha center. “Plasma is a lifeline for thousands of people with rare, chronic and complex diseases, and we are excited to open the first BioLife plasma collection center in Nebraska.”
Through a simple, low-risk process called plasmapheresis, plasma is separated from the blood and the blood elements are returned back into the donor’s body. Screened plasma collected from healthy individuals is processed into a wide variety of therapeutics for people around the world with rare, life-threatening diseases, such as immunodeficiency disorders, hemophilia, and hereditary angioedema.
Due to the COVID-19 pandemic, BioLife Plasma Services has implemented additional screening and safety measures in line with public health guidance to help guarantee the safety and health of donors and employees, as well as the safety of the collected plasma. All donors will need to wear a mask or other cloth face covering inside a BioLife Plasma center.
To learn more about BioLife Plasma Services, the donation process, and to schedule an appointment, please visit www.biolifeplasma.com.